ALEXANDRIA, Va., June 19 -- United States Patent no. 12,329,781, issued on June 17, was assigned to Minovia Therapeutics Ltd. (Tirat Hacarmel, Israel).
"Mitochondrial augmentation therapy of renal diseases" was invented by Natalie Yivgi Ohana (Haifa, Israel), Uriel Halavee (Tel Aviv, Israel), Shmuel Bukshpan (Ramat Hasharon, Israel), Moriya Blumkin (Tel Aviv, Israel) and Noa Sher (Haifa, Israel).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides stem cells enriched with healthy functional mitochondria, pharmaceutical compositions comprising these cells and methods of use thereof for treating renal diseases, disorders and symptoms thereof where the disease may or may not be associate...